Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

From rising tariffs and stricter regulations to the increasing complexity of global sourcing, pharmaceutical importers are ...

Pharmexcil and Mexican Consulate join hands to chart new avenues for Indian pharma expansion: Shardul Nautiyal, Mumbai Tuesday, August 12, 2025, 08:00 Hrs [IST] In a bid to unlock ...

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

BNP Secretary General Mirza Fakhrul Islam Alamgir has warned of a severe crisis in the pharmaceutical industry, alleging that ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...